This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takasaki, I. Articles by Brecher, P. Search for Related Content PubMed PubMed Citation Articles by Takasaki, I. Articles by Brecher, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB SODIUM CHLORIDE

Hypertension, Vol 20, 20-25, Copyright © 1992 by American Heart Association

ARTICLES

Hypertension induces alternatively spliced forms of fibronectin in rat aorta

I Takasaki, AV Chobanian, WS Mamuya and P Brecher
Department of Biochemistry, Boston University School of Medicine, MA 02118.

Fibronectin expression was shown recently to increase in the rat aorta in response to experimental hypertension. Fibronectin is known to alter the phenotype of vascular smooth muscle and endothelial cells, and relative changes in the expression of different isoforms of fibronectin, generated by alternative splicing and distinguished by the absence or presence of inserts designated as EIIIA, EIIIB, and V, may reflect a change in cell phenotype. In the present study we examined the expression of alternatively spliced forms of aortic fibronectin during deoxycorticosterone-salt hypertension. Aortic RNA was analyzed quantitatively using Northern blot analysis and ribonuclease protection assays. Using Northern blot analysis, deoxycorticosterone-salt treatment for 21 days led to a 4.9-fold increase in EIIIA fibronectin messenger RNA, while EIIIB and V forms increased by 2.6- and 2.5-fold, respectively. As determined by ribonuclease protection assays, the percentage of fibronectin transcripts containing either EIIIA, EIIIB, or V in control aorta was 7.3%, 19%, and 40%, respectively. The percentage of EIIIA transcripts increased 42% over control levels after 21 days of deoxycorticosterone-salt treatment, whereas no proportionate change in the other alternatively spliced forms was found. Thus, all forms increased, but a selective increase in the EIIIA form was induced. Analogous increases in each of the fibronectin isoforms were found in the spontaneously hypertensive rats when compared with age- matched Wistar-Kyoto or Wistar rats, and 40-week-old animals showed increases over 10-week-old animals in all strains, consistent with an age-dependent increase in aortic fibronectin expression.

This article has been cited by other articles:

				E. H.J. Heerkens, L. Shaw, A. Ryding, G. Brooker, J. J. Mullins, C. Austin, V. Ohanian, and A. M. Heagerty {alpha}V Integrins Are Necessary for Eutrophic Inward Remodeling of Small Arteries in Hypertension Hypertension, February 1, 2006; 47(2): 281 - 287. [Abstract] [Full Text] [PDF]

				S. Astrof, D. Crowley, E. L. George, T. Fukuda, K. Sekiguchi, D. Hanahan, and R. O. Hynes Direct Test of Potential Roles of EIIIA and EIIIB Alternatively Spliced Segments of Fibronectin in Physiological and Tumor Angiogenesis Mol. Cell. Biol., October 1, 2004; 24(19): 8662 - 8670. [Abstract] [Full Text] [PDF]

				Y.-F. Liao, P. J. Gotwals, V. E. Koteliansky, D. Sheppard, and L. Van De Water The EIIIA Segment of Fibronectin Is a Ligand for Integrins alpha 9beta 1 and alpha 4beta 1 Providing a Novel Mechanism for Regulating Cell Adhesion by Alternative Splicing J. Biol. Chem., April 19, 2002; 277(17): 14467 - 14474. [Abstract] [Full Text] [PDF]

				A. Zuk, J. V. Bonventre, and K. S. Matlin Expression of fibronectin splice variants in the postischemic rat kidney Am J Physiol Renal Physiol, June 1, 2001; 280(6): F1037 - F1053. [Abstract] [Full Text] [PDF]

				Y.-F. Liao, K. G. Wieder, J. M. Classen, and L. V. De Water Identification of Two Amino Acids within the EIIIA (ED-A) Segment of Fibronectin Constituting the Epitope for Two Function-blocking Monoclonal Antibodies J. Biol. Chem., June 18, 1999; 274(25): 17876 - 17884. [Abstract] [Full Text] [PDF]

				K. Tamura, N. Nyui, N. Tamura, T. Fujita, M. Kihara, Y. Toya, I. Takasaki, N. Takagi, M. Ishii, K.-i. Oda, et al. Mechanism of Angiotensin II-mediated Regulation of Fibronectin Gene in Rat Vascular Smooth Muscle Cells J. Biol. Chem., October 9, 1998; 273(41): 26487 - 26496. [Abstract] [Full Text] [PDF]

				M. K. Magnusson and D. F. Mosher Fibronectin : Structure, Assembly, and Cardiovascular Implications Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1363 - 1370. [Full Text] [PDF]

				Y. Bezie, J.-M. D. Lamaziere, S. Laurent, P. Challande, R. S. Cunha, J. Bonnet, and P. Lacolley Fibronectin Expression and Aortic Wall Elastic Modulus in Spontaneously Hypertensive Rats Arterioscler Thromb Vasc Biol, July 1, 1998; 18(7): 1027 - 1034. [Abstract] [Full Text] [PDF]

				T. Takizawa, M. Gu, A. V. Chobanian, and P. Brecher Effect of Nitric Oxide on DNA Replication Induced by Angiotensin II in Rat Cardiac Fibroblasts Hypertension, November 1, 1997; 30(5): 1035 - 1040. [Abstract] [Full Text]

				F. W. Dunn, M.-H. Roux, F. Farhadian, K. Sabri, C. Ossart, J. L. Samuel, L. Rappaport, and G. Hamon HR 720, A Novel Angiotensin Receptor Antagonist Inhibits the Angiotensin II-Induced Trophic Effects, Fibronectin Release and Fibronectin-EIIIA+ Expression in Rat Aortic Vascular Smooth Muscle Cells in Vitro J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 447 - 453. [Abstract] [Full Text]

				R. Saeid Farivar, A. V. Chobanian, and P. Brecher Salicylate or Aspirin Inhibits the Induction of the Inducible Nitric Oxide Synthase in Rat Cardiac Fibroblasts Circ. Res., May 1, 1996; 78(5): 759 - 768. [Abstract] [Full Text]

				D. Dubin, J. H. Peters, L. F. Brown, B. Logan, K. C. Kent, B. Berse, S. Berven, B. Cercek, B. G. Sharifi, R. E. Pratt, et al. Balloon Catheterization Induces Arterial Expression of Embryonic Fibronectins Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1958 - 1967. [Abstract] [Full Text]

				N. Bardy, G. J. Karillon, R. Merval, J.-L. Samuel, and A. Tedgui Differential Effects of Pressure and Flow on DNA and Protein Synthesis and on Fibronectin Expression by Arteries in a Novel Organ Culture System Circ. Res., October 1, 1995; 77(4): 684 - 694. [Abstract] [Full Text]

				C. Bauters, F. Marotte, M. Hamon, P. Oliviero, F. Farhadian, V. Robert, J. L. Samuel, and L. Rappaport Accumulation of Fetal Fibronectin mRNAs After Balloon Denudation of Rabbit Arteries Circulation, August 15, 1995; 92(4): 904 - 911. [Abstract] [Full Text]